FDA Slaps Stem Cell Firm Linked to Nebraska Infections

June 25, 2020

(Medscape) – The FDA has identified Las Vegas-based EUCYT Laboratories as the company whose exosome products sickened patients in Nebraska late last year, according to a recent warning letter. The agency also warned EUCYT for marketing an exosome product COVIXO that it claimed could treat COVID-19.